Clinical Study of Risk Factors for Early Human Cytomegalovirus Reactivation Following Liver Transplantation
Transplantation Proceedings · 2026-05 · 58 (4) · 739-747
DOI: 10.1016/j.transproceed.2026.03.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation Proceedings, 2026-05. Verfasst von Yanyue Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua Municipal Central Hospital Medical Grou…. Hauptthemen laut MEDLINE: Liver Transplantation, Cytomegalovirus Infections, Virus Activation, Cytomegalovirus. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Department of Health of Zhejiang Province, Zhejiang University, Zhejiang Province Natural Science Foundation.
Abstract (Originalsprache)
BACKGROUND Human cytomegalovirus (HCMV) is the most common opportunistic infection following liver transplantation (LT). This study aimed to identify risk factors for HCMV reactivation early post-transplantation. METHODS We retrospectively analyzed data from 150 LT recipients aged ≥14 years who received preemptive therapy in China from July 2017 to December 2018. We performed univariate and multivariate analyses to identify risk factors for HCMV reactivation within the first 90 days post-transplantation. RESULTS HCMV reactivation occurred in 32 patients (21.33%) within the first 90 days post-LT. Intensive care unit length of stay (odds ratio [OR], 1.055; 95% confidence interval [CI], 1.007-1.104; P = .023), fungal infections (OR, 3.093; 95% CI, 1.092-8.764; P = .034), and non-hepatitis B virus (HBV)-related liver disease (OR, 5.576; 95% CI, 2.137-14.552; P = .000) were significant risk factors for HCMV reactivation within the first 90 days post-LT. The cumulative incidence of HCMV reactivation was significantly higher in patients with non-HBV-related liver diseases (P = .0007) than in those with HBV-related liver diseases. In the former, HCMV reactivation early after transplantation was associated with the pretransplantation hepatitis B surface antibody (HBsAb) serological status (P = .006). Higher HBsAb titers were significantly associated with reduced HCMV reactivation risk (P = .011). CONCLUSIONS This study suggested that HCMV is a common opportunistic infection early after LT. Reducing intensive care unit lengths of stay and preventing fungal infections may reduce the risk of HCMV reactivation early after transplantation. Pretransplantation HBsAb titers might be a useful predictor in patients with non-HBV-related liver diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Clinical Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua Municipal Central Hospital Medical Group, Jinhua, China.
- State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Centre for Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, The…
Förderung
- Department of Health of Zhejiang Province
- Zhejiang University
- Zhejiang Province Natural Science Foundation
Zitieren
APA
Zhang, Y., Gui, G., Yu, X., Fan, J., & Pan, X. (2026). Clinical Study of Risk Factors for Early Human Cytomegalovirus Reactivation Following Liver Transplantation. Transplantation Proceedings, 58(4), 739-747. https://doi.org/10.1016/j.transproceed.2026.03.007
Vancouver
Zhang Y, Gui G, Yu X, Fan J, Pan X. Clinical Study of Risk Factors for Early Human Cytomegalovirus Reactivation Following Liver Transplantation. Transplantation Proceedings. 2026;58(4):739-747. doi:10.1016/j.transproceed.2026.03.007
BibTeX
@article{Zhang2026,
author = {Zhang, Yanyue and Gui, Genyong and Yu, Xiaopeng and Fan, Jun and Pan, Xiaoping},
title = {Clinical Study of Risk Factors for Early Human Cytomegalovirus Reactivation Following Liver Transplantation},
journal = {Transplantation Proceedings},
year = {2026},
volume = {58},
number = {4},
pages = {739--747},
doi = {10.1016/j.transproceed.2026.03.007}
}
EUVIMED